drugset / Trial / NCT04507971
Effects of MET-3 and MET-5 on Gut Microbiome and Metabolic Function in Men and Women With Hypertriglyceridemia
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this pilot study is to determine the effects of two human microbiome formulations (MET-3 and MET-5) on fasting serum TG concentration.
Timeline
- Start
- 2020-06-22
- Primary completion
- 2021-12-31
- Completion
- 2021-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MET-3 | Other / unclassified | 2.5 g | Oral |
| Subject | MET-5 | Other / unclassified | 2.5 g | Oral |